AlAnizy Layla, AlMatham Khalid, Al Basheer Asmaa, AlFayyad Isamme
Department of Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia.
Department of Internal Medicine, King Fahad Medical City, Riyadh, Saudi Arabia.
Int J Nephrol Renovasc Dis. 2020 Jan 29;13:11-18. doi: 10.2147/IJNRD.S240705. eCollection 2020.
Complementary and alternative medicine (CAM) practice in patients with chronic kidney disease (CKD) has significantly increased. However, statistics regarding CAM practices among patients with CKD in Saudi and worldwide are limited. Hence, this study aimed to explore the prevalence and types of CAM in Saudi patients with CKD.
A cross-sectional study was conducted in 315 patients, who were divided into CKD stages 3-4, CKD stage 5-hemodialysis, and kidney transplant with functioning allografts, by using a convenience sampling technique between September and December 2018. Next, they answered a self-administered questionnaire. The study outcomes were the prevalence of CAM, CAM types, reasons for using herbs, and the source of information about CAM.
Overall, 54.9% of the study participants were current CAM users, of which 88.4% were herbal consumers. Patients with CKD stages 3-4 accounted for 87.3% of the CAM users, followed by those with CKD 5-hemodialysis (7.5%) and CKD-transplant recipients (5.2%). CAM practice was associated with monthly income (P = 0.021). Meanwhile, 79% of CAM users did not report their CAM practices to their primary physicians. and parsley were the most commonly consumed herbs by CAM users [94 (61.4%) and 78 (51%), respectively].
CAM practice and herb consumption were highly prevalent among patients with CKD. Patients inadequately inform the primary physicians about their CAM practices. Therefore, healthcare providers are encouraged to inquire about these practices.
慢性肾脏病(CKD)患者使用补充和替代医学(CAM)的情况显著增加。然而,沙特及全球范围内CKD患者使用CAM的统计数据有限。因此,本研究旨在探讨沙特CKD患者中CAM的患病率及类型。
2018年9月至12月,采用便利抽样技术,对315例患者进行了横断面研究,这些患者被分为CKD 3 - 4期、CKD 5期 - 血液透析以及具有功能正常同种异体移植物的肾移植患者。接下来,他们回答了一份自填式问卷。研究结果包括CAM的患病率、CAM类型、使用草药的原因以及CAM信息来源。
总体而言,54.9%的研究参与者目前使用CAM,其中88.4%为草药使用者。CKD 3 - 4期患者占CAM使用者的87.3%,其次是CKD 5期 - 血液透析患者(7.5%)和CKD移植受者(5.2%)。CAM的使用与月收入相关(P = 0.021)。同时,79%的CAM使用者未向其初级医生报告他们使用CAM的情况。迷迭香和欧芹是CAM使用者最常食用的草药[分别为94例(61.4%)和78例(51%)]。
CKD患者中CAM的使用和草药消费非常普遍。患者未充分告知初级医生他们使用CAM的情况。因此,鼓励医疗服务提供者询问这些情况。